HomeCompareADDLF vs SBUX

ADDLF vs SBUX: Dividend Comparison 2026

ADDLF yields 0.19% · SBUX yields 2.84%● Live data

vsPost on X →
After 10 years · $10,000 invested · DRIP enabled
🏆 SBUX wins by $143.6K in total portfolio value
10 years
ADDLF
ADDLF
● Live price
0.19%
Share price
$42.00
Annual div
$0.08
5Y div CAGR
49%
Payout ratio
50%
After 10 yrs · $10,000 · DRIP
Portfolio value
$23.4K
Annual income
$1,143.40
Full ADDLF calculator →
SBUX
SBUX
● Live price
2.84%
Share price
$86.72
Annual div
$2.46
5Y div CAGR
48.3%
Payout ratio
50%
After 10 yrs · $10,000 · DRIP
Portfolio value
$167.0K
Annual income
$71,136.45
Full SBUX calculator →

Portfolio growth — ADDLF vs SBUX

📍 SBUX pulled ahead of the other in Year 1

Annual dividend income

🛡️

Recession Test — Did They Cut Dividends?

How each stock treated shareholders during the 3 biggest crises of the last 20 years

Crisis PeriodADDLFSBUX
2008–2009
GFC
— No data— No data
2020 Q1–Q2
COVID
— No data— No data
2022 Q4
Rate Hike
— No data— No data
Based on dividend payment history. "Increased" = dividend grew during crisis. "Maintained" = held within 3%. "Cut" = reduced by more than 3%.
📅

Dividend Calendar Overlap

Combined, ADDLF + SBUX cover 0 of 12 monthsgood coverage

Jan
Feb
Mar
Apr
May
Jun
Jul
Aug
Sep
Oct
Nov
Dec
ADDLF pays
SBUX pays
Both pay
Neither
💰

Tax Bracket Optimizer

Which stock is actually better after tax? Adjust your rate to find out.

ADDLF
Annual income on $10K today (after 15% tax)
$15.94/yr
After 10yr DRIP, annual income (after tax)
$971.89/yr
SBUX
Annual income on $10K today (after 15% tax)
$241.12/yr
After 10yr DRIP, annual income (after tax)
$60,465.98/yr
At 15% tax rate, SBUX beats the other by $59,494.09/year in after-tax income after 10 years on $10,000
⚖️

Lazy Portfolio Split Optimizer

What's the optimal mix of ADDLF + SBUX for your $10,000?

ADDLF: 50%SBUX: 50%
100% SBUX50/50100% ADDLF
Portfolio after 10yr
$95.2K
Annual income
$36,139.93/yr
Blended yield
37.96%
📊

Analyst Conviction Gap

Where Wall Street is most bullish on SBUX right now

ADDLF
No analyst data
Altman Z
5.0
Piotroski
8/9
SBUX
Analyst Ratings
28
Buy
27
Hold
3
Sell
Consensus: Buy
Price Target
$104.00
+19.9% upside vs current
Range: $90.00 — $120.00
Altman Z
2.6
Piotroski
5/9
Analyst ratings via FMP. Altman Z-Score: >3.0 safe, 1.81–3.0 grey zone, <1.81 distress. Piotroski: 7–9 strong, 0–3 weak.
🏛️

Copy Congress — What Are Politicians Buying?

Senate & House STOCK Act disclosures (last 90 days)

ADDLF buys
0
SBUX buys
0
No recent congressional trades found for ADDLF or SBUX in the last 90 days.
STOCK Act mandates disclosure within 45 days of transaction. Data via FMP.Full tracker →
MetricADDLFSBUX
Forward yield0.19%2.84%
Annual dividend / share$0.08$2.46
Payout ratio50%50%
1-year div growth0%0%
5-year div CAGR49%48.3%
Portfolio after 10y$23.4K$167.0K
Annual income after 10y$1,143.40$71,136.45
Total dividends collected$3.3K$136.4K
Payment frequencyquarterlyquarterly
SectorStockConsumer Discretionary

Year-by-year: ADDLF vs SBUX ($10,000, DRIP)

YearADDLF PortfolioADDLF Income/yrSBUX PortfolioSBUX Income/yrGap
1← crossover$10,728$27.93$11,121$420.68$393.00SBUX
2$11,521$41.73$12,548$648.40$1.0KSBUX
3$12,389$62.40$14,440$1,013.98$2.1KSBUX
4$13,350$93.45$17,068$1,617.30$3.7KSBUX
5$14,425$140.23$20,912$2,649.52$6.5KSBUX
6$15,646$210.99$26,875$4,499.29$11.2KSBUX
7$17,060$318.67$36,771$8,014.12$19.7KSBUX
8$18,738$483.86$54,542$15,197.11$35.8KSBUX
9$20,789$740.07$89,602$31,242.49$68.8KSBUX
10$23,388$1,143.40$167,011$71,136.45$143.6KSBUX

ADDLF vs SBUX: Complete Analysis 2026

ADDLFStock

AddLife AB (publ), together with its subsidiaries, provides equipment, medical devices, and reagents primarily to healthcare system, research, colleges, and universities, as well as the food and pharmaceutical industries. The company operates in two segments, Labtech and Medtech. The Labtech segment offers products, solutions, and services in the areas of diagnostics, and biomedical research and laboratory equipment for haematology, pathology, point-of-care diagnostics, cell biology, genetics, microbiology, virology, molecular biology, clinical chemistry, immunology, consumables, and analytical instruments segments. This segment also offers support, maintenance, advice, and training services. The Medtech segment provides medical device products for surgery, respiration, intensive care, wound care, enteral nutrition, fall prevention, welfare technology, ear, and nose and throat segments, as well as bathroom-related assistive devices and assistive devices for children with disabilities. It operates in Sweden, Finland, Denmark, Norway, the United Kingdom, Ireland, Germany, Italy, Austria, Switzerland, rest of Europe, and internationally. AddLife AB (publ) was founded in 1906 and is based in Stockholm, Sweden.

Full ADDLF Calculator →

SBUXConsumer Discretionary

Starbucks Corporation, together with its subsidiaries, operates as a roaster, marketer, and retailer of specialty coffee worldwide. The company operates through three segments: North America, International, and Channel Development. Its stores offer coffee and tea beverages, roasted whole beans and ground coffees, single serve products, and ready-to-drink beverages; and various food products, such as pastries, breakfast sandwiches, and lunch items. The company also licenses its trademarks through licensed stores, and grocery and foodservice accounts. The company offers its products under the Starbucks, Teavana, Seattle's Best Coffee, Evolution Fresh, Ethos, Starbucks Reserve, and Princi brands. As of October 3, 2021, it operated 16,826 company-operated and licensed stores in North America; and 17,007 company-operated and licensed stores internationally. The company was founded in 1971 and is based in Seattle, Washington.

Full SBUX Calculator →
📬

Get this ADDLF vs SBUX comparison by email

Save your analysis + weekly dividend insights. Free forever.

More comparisons

ADDLF vs SCHDADDLF vs JEPIADDLF vs OADDLF vs KOADDLF vs MAIN

⚠️ Educational purposes only. Not financial advice. Congressional trades sourced from SEC STOCK Act filings via FMP. Past performance does not guarantee future results.